What's new

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 55, Status: Authorised

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 55, Status: Authorised

May 14, 2025 - 14:50
 0
Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 55, Status: Authorised
Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 55, Status: Authorised
Read More

Tags:

Previous Article

‘I don’t know that’: Federal judge flags factual claims in NIH grant termination...

Next Article

Human medicines European public assessment report (EPAR): Isentress, raltegravir...

Related Posts

Human medicines European public assessment report (EPAR): Bortezomib Sun, bortezomib, Date of authorisation: 22/07/2016, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

May 6, 2025  0

Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR...

May 8, 2025  0

Workshop on the use of Bayesian statistics in clinical development, Online, European Medicines Agency, Amsterdam, the Netherlands, 17 June 2025

Workshop on the use of Bayesian statistics in clinical ...

May 7, 2025  0